ARMONK, New York, August 23, 2026, 08:36 EDT
- IBM ended Friday at $235.68, marking a 14.53% increase compared to its July 22 closing price.
- The stock is currently just 3.92% under the average target price set by Wall Street analysts.
- Software revenue rose 5% in the latest quarter, whereas infrastructure revenue declined by 7%.
- A recent quantum breakthrough introduces new options, but short-term performance will be crucial for the stock.
International Business Machines Corporation NYSE:IBM has climbed 14.53% following its July earnings. With that gain, the stock is now 3.92% below the consensus price target from analysts. The straightforward phase of the rerating could be finished.
IBM ended Friday’s session at $235.68, gaining 0.85%. Over the five trading days since August 14, the stock advanced 0.58%. U.S. markets remain shut over the weekend.
| Date | Close | Daily move | Volume |
|---|---|---|---|
| Aug. 17 | $228.85 | -2.33% | 6.84 million |
| Aug. 18 | $232.67 | +1.67% | 3.90 million |
| Aug. 19 | $237.16 | +1.93% | 5.24 million |
| Aug. 20 | $233.69 | -1.46% | 4.03 million |
| Aug. 21 | $235.68 | +0.85% | 3.80 million |
The increase on Friday outperformed the S&P 500 but lagged behind two other services peers. The gain was in line with the Dow’s uptick. This pattern points to sector-wide momentum rather than a new catalyst specific to the company.
| Share or index | Friday move | Relative to IBM |
|---|---|---|
| Accenture plc NYSE:ACN | up 2.17% | 1.32 points higher |
| Cognizant Technology Solutions Corporation NASDAQ:CTSH | rose 1.56% | 0.71 points higher |
| IBM | gained 0.85% | — |
| Dow Jones Industrial Average | added 0.98% | up 0.13 points |
| S&P 500 | advanced 0.43% | down 0.42 points |
The discussion around IBM’s valuation begins with its mixed operating results. For the second quarter, IBM reported revenue of $17.16 billion, a 1% increase. Software revenue improved by 5%, supported by an 11% rise in Red Hat sales. In contrast, infrastructure revenue declined 7%, driven by a 42% drop in IBM Z revenue.
| Q2 metric | Result | Year-on-year change |
|---|---|---|
| Total revenue | $17.16 billion | up 1% |
| Software revenue | $7.76 billion | increased 5% |
| Consulting revenue | $5.33 billion | unchanged |
| Infrastructure revenue | $3.84 billion | down 7% |
| Adjusted diluted EPS | $2.93 | rose 5% |
| Free cash flow | $2.5 billion | fell by $0.3 billion |
Management continues to project constant-currency revenue growth of 4% to 5% for 2026. The company also anticipates generating approximately $1 billion in additional free cash flow compared to the previous year. These figures reflect company guidance rather than actual reported results.
IBM is maintaining confidence in its strategy and portfolio, according to Chief Executive Arvind Krishna. Chief Financial Officer James Kavanaugh flagged late-quarter revenue headwinds. The distinction is key, as investors require cash growth to surpass the sluggish infrastructure cycle.
There is minimal flexibility in the analyst baseline. The consensus target price averages $244.91, with a median of $245. However, projections span from $174 to $350, highlighting an unusually broad gap in expectations for IBM’s future growth resilience.
| Analyst measure | Value | Implied move from $235.68 |
|---|---|---|
| Consensus rating | Buy | — |
| Strong Buy / Buy | 13 analysts | — |
| Hold | 10 analysts | — |
| Sell / Strong Sell | 2 analysts | — |
| Average target | $244.91 | +3.92% |
| Low target | $174 | -26.17% |
| High target | $350 | +48.51% |
IBM introduced a long-term driver on Wednesday, linking and cooling two modular cryogenic systems under 15 millikelvin. The company described the achievement as a milestone on the path to building a system with no fewer than 1,000 programmable qubits by 2027.
Jay Gambetta, head of IBM Research, described the connection as “a leap forward.” The project could help reinforce IBM’s technology lead. However, it will not, on its own, resolve the company’s quarterly revenue composition.
The upcoming week hinges on follow-through. Investors are advised to monitor if the stock remains above the $233 level. Tracking software demand and any indication that consulting growth can resume will also be key.
Risks: Accelerated software expansion or breakthroughs in quantum technology could push IBM above consensus targets. On the other hand, soft consulting demand, decreased infrastructure revenues or higher debt from acquisitions could undermine the recovery.
Related articles: NYSE:IBM
